• to reduce the risk of serious cardiovascular (heart and blood vessel) complications in Grownups with style 2 diabetes and heart problemsIn Oct 2024, Novo Nordisk published a review on scientific journal Character about a novel glucose-sensitive insulin NNC2215 that could decrease the potential risk of hypoglycemia in animal types.[67]significan